Biologic Response to Polymer-coated Stents: In Vitro Analysis and Results in an Iliac Artery Sheep Model

Radiology

Volumn 230, Issue 1, 2004, Pages 151-162

  Schürmann, Karl ^a   Lahann, Joerg ^b   Niggemann, Pascal ^a   Klosterhalfen, Bernd ^a   Meyer, Julius ^a   Kulisch, Arthur ^a   Klee, Doris ^a   Günther, Rolf W ^a   Vorwerk, Dierk ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c Ingolstadt Clinic   (Germany)

Author keywords

Animals; Arteries, grafts and prostheses; Arteries, stenosis or obstruction; Experimental study

Indexed keywords

HEPARIN; IOPAMIDOL; NITINOL; POLY(HYDROXYMETHYL 4 XYLYLENE CO 4 XYLYLENE); POLYMER; STAINLESS STEEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CYTOTOXICITY; FOLLOW UP; HISTOLOGY; ILIAC ARTERY; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SHEEP; STENT; VASCULAR PATENCY;

ANIMALS; ILIAC ARTERY; MALE; POLYMERS; SHEEP; STENTS;

EID: 0347288604     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2301021071     Document Type: Article

References (37)

1. Palmaz JC, Richter GM, Noeldge G, et al. Intraluminal stents in atherosclerotic iliac artery stenosis: preliminary report of a multicenter study. Radiology 1988; 168:727-731.
2. Strecker EP, Romaniuk P, Schneider B, et al. Perkutan implantierbare, durch ballon aufdehnbare gefässprothese. Dtsch Med Wochenschr 1988; 113:538-542.
3. Vorwerk D, Günther RW, Schürmann K, Wendt G. Aortic and iliac stenoses: follow-up results of placement after insufficient balloon angioplasty. Radiology 1996; 198:45-48.
4. Vorwerk D, Guenther RW, Schürmann K, Wendt G, Peters I. Primary stent placement for chronic iliac artery occlusions: follow-up results in 103 patients. Radiology 1995; 194:745-749.
5. Palmaz JC. Intravascular stents: tissue-stent interactions and design considerations. AJR Am J Roentgenol 1993; 160:613-618.
6. Zollikofer CL, Antonucci F, Stuckmann G, Mattias P, Salomonowitz EK. Historical overview on the development and characteristics of stents and future outlook. Cardiovasc Intervent Radiol 1992; 15:272-278.
7. Schürmann K, Vorwerk D, Uppenkamp R, Klosterhalfen B, Bücker A, Günther RW. Iliac arteries: plain and heparin-coated Dacron-covered stent-grafts compared with noncovered metal stents - an experimental study. Radiology 1997; 203:55-63.
8. Alt E, Haehnel I, Beilharz C, et al. Inhibition of neointimal formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Circulation 2000; 101:1453-1458.
9. Drachman DE, Edelman ER, Seifert P, et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over 6 months. J Am Coll Cardiol 2000; 36:2325-2332.
10. Kastrati A, Schomig A, Dirschinger J, et al. Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 2000; 101:2478-2483.
11. Edelman ER, Seifert P, Groothuis A, Morss A, Bornstein D, Rogers C. Gold-coated NIR stents in porcine coronary arteries. Circulation 2001; 103:429-434.
12. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104:2007-2011.
13. Windecker S, Mayer I, De Pasquale G, et al. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation 2001; 104:928-933.
14. Whelan DM, van Beusekom HM, van der Giessen WJ. Mechanisms of drug loading and release kinetics. Semin Interv Cardiol 1998; 3:127-131.
15. Rosanio S, Tocchi M, Patterson C, Runge MS. Prevention of restenosis after percutaneous coronary interventions: the medical approach. Thromb Haemost 1999; 82:164-170.
16. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation 1996; 93:412-422.
17. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94:1690-1697.
18. Lincoff AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997; 29:808-816.
19. De Scheerder IK, Wilczek KL, Verbeken EV, et al. Biocompatibility of biodegradable and nonbiodegradable polymer-coated stents implanted in porcine peripheral arteries. Cardiovasc Intervent Radiol 1995; 18:227-232.
20. Fontaine AB, Koelling K, Passos SD, Cearlock J, Hoffman R, Spigos DG. Polymeric surface modifications of tantalum stents. J Endovasc Surg 1996; 3:276-283.
21. Lahann J, Klee D, Thelen H, Bienert H, Vorwerk D, Höcker H. Improvement of haemocompatibility of metallic stents by polymer coating. J Mater Sci Mater Med 1999; 10:443-448.
22. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neo-intimal formation in a porcine coronary model. Circulation 2001; 104:1188-1193.
23. Wohrle J, Al-Khayer E, Grotzinger U, et al. Comparison of the heparin coated vs the uncoated Jostent: no influence on restenosis or clinical outcome. Eur Heart J 2001; 22:1808-1816.
24. Lahann J, Klee D, Höcker H. Chemical vapour deposition polymerization of substituted [2.2]paracyclophanes. Macromol Rapid Commun 1998; 19:441-444.
25. Lahann J, Klee D, Pluester W, Hoecker H. Bioactive immobilization of r-hirudin on CVD-coated metallic implant devices. Biomaterials 2001; 22:817-826.
26. De Gennes PG. Wetting: statistics and dynamics. Rev Mod Phys 1985; 57:827-863.
27. Frank RD, Dresbach H, Thelen H, Sieberth HG. Glutaraldehyde induced fluorescence technique (GIFT): a new method for the imaging of platelet adhesion on biomaterials. J Biomed Mater Res 2000; 52:374-381.
28. Porstmann T, Ternynck T, Avrameas S. Quantitation of 5-bromo-2-deoxyuridine incorporation into DNA: an enzyme immunoassay for the assessment of the lymphoid cell proliferative response. J Immunol Methods 1985; 82:169-179.
29. Eskin SG, Armeniades CD, Lie JT, Trevino L, Kennedy JH. Growth of cultured calf aortic smooth muscle cells on cardiovascular prosthetic materials. J Biomed Mater Res 1976; 10:113-122.
30. Licklider L, Wang XQ, Desai A, Tai YC, Lee TD. A micromachined chip-based electrospray source for mass spectrometry. Anal Chem 2000; 72:367-375.
31. De Scheerder IK, Wilczek KL, Verbeken EV, et al. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis 1995; 114:105-114.
32. Herrmann R, Schmidmaier G, Markl B, et al. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 1999; 82:51-57.
33. Alt E, Seliger C. Antithrombotic stent coatings: hirudin/iloprost combination. Semin Interv Cardiol 1998; 3:177-183.
34. Schürmann K, Vorwerk D, Bücker A, Grosskortenhaus S, Günther RW. Single and tandem stents in sheep iliac arteries: is there a difference in patency? Cardiovasc Intervent Radiol 1998; 21:411-418.
35. Hecker J. Haematology. In: The sheep as an experimental animal. London, England: Academic Press, 1983; 40-48.
36. Karges HE, Funk KA, Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 1994; 44:793-797.
37. Narayanaswamy M, Wright KC, Kandarpa K. Animal models for atherosclerosis, restenosis, and endovascular graft research. J Vasc Interv Radiol 2000; 11:5-17.